RUBIUS THERAPEUTICS INC's ticker is RUBY and the CUSIP is 78116T103. A total of 109 filers reported holding RUBIUS THERAPEUTICS INC in Q4 2021. The put-call ratio across all filers is 0.96 and the average weighting 0.1%.
Links
Filings
- All filings
- Annual reports (10-K)
- Quarterly reports (10-Q)
- Insider transactions
- Shareholder votes
- Significant ownership
- Events
EDGAR links
External links
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2022 | $231 | -76.9% | 1,342 | +4.4% | 0.00% | – |
| Q3 2022 | $1,000 | -50.0% | 1,286 | -35.0% | 0.00% | – |
| Q2 2022 | $2,000 | -98.9% | 1,978 | -93.9% | 0.00% | – |
| Q1 2022 | $177,000 | -86.7% | 32,180 | -76.6% | 0.00% | -100.0% |
| Q4 2021 | $1,330,000 | -21.7% | 137,351 | +44.7% | 0.00% | 0.0% |
| Q3 2021 | $1,698,000 | -62.6% | 94,951 | -48.9% | 0.00% | -66.7% |
| Q2 2021 | $4,535,000 | +2699.4% | 185,780 | +2944.1% | 0.00% | – |
| Q1 2021 | $162,000 | +95.2% | 6,103 | -44.3% | 0.00% | – |
| Q4 2020 | $83,000 | +118.4% | 10,953 | +42.7% | 0.00% | – |
| Q3 2020 | $38,000 | -62.4% | 7,675 | -54.7% | 0.00% | – |
| Q2 2020 | $101,000 | +40.3% | 16,951 | +4.6% | 0.00% | – |
| Q1 2020 | $72,000 | -47.8% | 16,212 | +11.2% | 0.00% | – |
| Q4 2019 | $138,000 | +360.0% | 14,575 | +280.7% | 0.00% | – |
| Q3 2019 | $30,000 | -83.5% | 3,828 | -67.0% | 0.00% | – |
| Q2 2019 | $182,000 | -2.2% | 11,615 | +12.9% | 0.00% | – |
| Q1 2019 | $186,000 | +126.8% | 10,289 | +202.6% | 0.00% | – |
| Q3 2018 | $82,000 | – | 3,400 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| CONCOURSE FINANCIAL GROUP SECURITIES, INC. | 0 | $0 | 0.00% |